UBS Group’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Sell |
1,344,199
-162,557
| -11% | -$374K | ﹤0.01% | 3459 |
|
|
2025
Q1 | $6.52M | Buy |
1,506,756
+190,659
| +14% | +$826K | ﹤0.01% | 2746 |
|
|
2024
Q4 | $2.5M | Buy |
1,316,097
+675,441
| +105% | +$1.28M | ﹤0.01% | 3540 |
|
|
2024
Q3 | $2.52M | Sell |
640,656
-13,783
| -2% | -$54.2K | ﹤0.01% | 2848 |
|
|
2024
Q2 | $4.28M | Sell |
654,439
-238,986
| -27% | -$1.56M | ﹤0.01% | 2249 |
|
|
2024
Q1 | $5.45M | Buy |
893,425
+839,347
| +1,552% | +$5.12M | ﹤0.01% | 2111 |
|
|
2023
Q4 | $679K | Sell |
54,078
-56,006
| -51% | -$703K | ﹤0.01% | 3740 |
|
|
2023
Q3 | $1.96M | Sell |
110,084
-151,498
| -58% | -$2.69M | ﹤0.01% | 2561 |
|
|
2023
Q2 | $4.54M | Buy |
261,582
+199,594
| +322% | +$3.46M | ﹤0.01% | 1988 |
|
|
2023
Q1 | $1.47M | Buy |
61,988
+27,600
| +80% | +$656K | ﹤0.01% | 2861 |
|
|
2022
Q4 | $555K | Sell |
34,388
-1,711
| -5% | -$27.6K | ﹤0.01% | 3621 |
|
|
2022
Q3 | $846K | Sell |
36,099
-12,959
| -26% | -$304K | ﹤0.01% | 2975 |
|
|
2022
Q2 | $1.07M | Sell |
49,058
-13,301
| -21% | -$290K | ﹤0.01% | 2842 |
|
|
2022
Q1 | $1.58M | Buy |
62,359
+15,634
| +33% | +$396K | ﹤0.01% | 2856 |
|
|
2021
Q4 | $1.26M | Buy |
46,725
+12,803
| +38% | +$346K | ﹤0.01% | 3262 |
|
|
2021
Q3 | $889K | Buy |
33,922
+33,746
| +19,174% | +$884K | ﹤0.01% | 3340 |
|
|
2021
Q2 | $7K | Buy |
+176
| New | +$7K | ﹤0.01% | 7200 |
|